Koyfin Home > Directory > Health Care > Acorda Therapeutics > EV / Sales (ntm)

Acorda Therapeutics EV / Sales (ntm) Chart (ACOR)

Acorda Therapeutics annual/quarterly EV / Sales (ntm) from 2010 to 2020.
  • Acorda Therapeutics EV / Sales (ntm) for the quarter ending October 10, 2020 was 1.90 a -9.60% decrease of -0.18 year over year
  • Acorda Therapeutics EV / Sales (ntm) for the last 12 months ending October 10, 2020 was 1.90 a -9.60% decrease of -0.18 year over year
  • Acorda Therapeutics Annual EV / Sales (ntm) for 2020 was 1.90 a -8.86% decrease of -0.17 from 2019
  • Acorda Therapeutics Annual EV / Sales (ntm) for 2020 was 2.07 a -0.45% decrease of -0.01 from 2019
  • Acorda Therapeutics Annual EV / Sales (ntm) for 2020 was 2.08 a -0.22% decrease of 0.00 from 2019
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.11 a 35.48% increase of 0.75 year over year
  • Acorda Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $1,138m a 2.19% increase of 25m year over year
View Chart On Koyfin

Quarterly ACOR EV / Sales (ntm) Data

10/20201.90
10/20202.07
10/20202.08
10/20202.08
10/20202.09
10/20202.08
10/20202.10
10/20202.06
10/20202.06
10/20202.05

Annual ACOR EV / Sales (ntm) Data

20201.90
20202.07
20202.08
20202.08
20202.09
20202.08
20202.10
20202.06
20202.06
20202.05